Voglibose Tablets IP 0.3mg
Description
Fedelty Health Care offers high-quality Voglibose Tablets IP 0.3mg, uncoated oral tablets manufactured under Indian Pharmacopoeia (IP) standards. Each tablet contains 0.3mg of Voglibose along with approved excipients and colorants. Voglibose is an alpha-glucosidase inhibitor that helps in the management of type 2 diabetes mellitus by delaying the digestion and absorption of carbohydrates in the intestines. This action effectively reduces the post-prandial (after meal) rise in blood glucose levels, helping to maintain better glycemic control.
Key Features
- Each uncoated tablet delivers 0.3mg of Voglibose, produced with stringent GMP quality standards.
- Works by inhibiting intestinal alpha-glucosidase enzymes, slowing complex carbohydrate breakdown into glucose.
- Manufactured under GMP-certified conditions ensuring purity, safety, and consistent potency.
- Suitable for use alongside diet and exercise regimens to manage blood sugar levels in type 2 diabetes.
- Stable formulation with reliable shelf life, packaged to support hospital, distributor, and export needs.
Therapeutic Uses
- Effective in controlling post-prandial hyperglycemia in type 2 diabetes mellitus.
- Used when diet and exercise alone do not provide adequate blood sugar control.
- Helps reduce the risk of macrovascular complications related to diabetes by managing glucose spikes.
- Often combined with other oral hypoglycemic agents for comprehensive diabetes management.
Dosage & Administration
- Typically administered orally just before meals as prescribed by a healthcare professional.
- Dosage and frequency tailored according to patient needs and glycemic response.
- Regular monitoring of blood glucose levels is recommended during therapy.
- Should be taken consistently to maintain steady blood sugar control.
Common Side Effects
- Possible gastrointestinal side effects such as flatulence (gas), abdominal discomfort, diarrhea, nausea, and constipation.
- Hypoglycemia risk is generally low when used alone but can increase if combined with insulin or sulfonylureas.
- Patients should consult their doctor if side effects persist or worsen.
Safety & Precautions
- Not recommended for patients with intestinal obstruction, inflammatory bowel diseases (e.g., ulcerative colitis, Crohn’s disease), or severe renal/hepatic impairment.
- Use with caution in elderly patients and those with a history of gastrointestinal issues.
- Pregnant and breastfeeding women should consult a physician before use.
- Avoid sudden discontinuation to prevent rebound hyperglycemia.
Why Choose Fedelty Health Care Voglibose Tablets?
- Trusted manufacturer and exporter of high-quality diabetic medication formulations.
- Manufactured in GMP-certified facilities to ensure international standards compliance.
- Competitive pricing and reliable bulk supply for international pharmaceutical markets.
- Dedicated customer support with export documentation and regulatory compliance assistance.
Ideal For
- Hospitals and clinics managing type 2 diabetes patients requiring effective post-prandial glucose control.
- Pharmaceutical distributors and wholesalers sourcing GMP-certified Voglibose tablets.
- International buyers seeking reliable diabetes management pharmaceutical products.
For bulk orders, pricing inquiries, or more information about Voglibose Tablets IP 0.3mg, please contact Fedelty Health Care, your trusted pharmaceutical manufacturing and export partner.
Fedelty Health Care is a leading manufacturer and exporter of Voglibose Tablets IP 0.3mg, formulated to support better glycemic control in patients with type 2 diabetes mellitus. Voglibose is an oral alpha-glucosidase inhibitor that delays the absorption of glucose, helping to reduce postprandial blood sugar spikes.
Our Voglibose tablets are manufactured in WHO-GMP certified facilities, ensuring consistent quality, safety, and compliance with international standards. We supply to global pharmaceutical distributors, hospitals, and procurement agencies in regulated and semi-regulated markets.
Export-Ready Formulation
Our products are packaged with clear labeling and batch traceability, making them suitable for government tenders and private markets across Africa, Asia, CIS, and Latin America.
For bulk orders, quotations, or more information about Voglibose Tablets IP 0.3mg, contact Fedelty Health Care, your trusted partner in pharmaceutical manufacturing and export.
